<DOC>
	<DOCNO>NCT00674115</DOCNO>
	<brief_summary>Open-label randomize crossover design study . 60 participant evaluate Day 1 compare effect stomach acid ; 30 participant continue treatment 7 day repeat evaluation Day 7 . The 30 participant receive single administration sodium bicarbonate .</brief_summary>
	<brief_title>A Pharmacodynamic Study Comparing Zegerid® Prilosec OTC® ( CL2007-17 ) ( P07813 ) ( COMPLETED )</brief_title>
	<detailed_description>Enrolled participant divide 2 group , 30 participant group . Group 1 : This group randomize 2-way crossover design added third period . These participant receive single administration ( day 1 dosing ) Zegerid Powder Oral Suspension , Prilosec OTC ( 20 mg omeprazole dose ) , 2-way randomized order , minimum 2-week washout period treatment leg . Following completion 2-way crossover study , subsequent washout period ( minimum 2 week ) , participant receive single administration sodium bicarbonate ( dose contain Zegerid Powder Oral Suspension ) Period 3 . This group underwent 24-hour intragastric pH study 3 dosing occasion . Group 2 : This group randomize 2-way crossover design receive 7 day administration Zegerid Powder Oral Suspension Prilosec OTC tablet , respectively . As prior group , minimum 2-week washout period treatment leg . Participants assign treatment group also underwent 24-hour intragastric pH recording day receive 1st last ( 7th ) dose two treatment drug . In addition detailed procedure , participant ( group ) underwent 24-hour baseline intragastric pH study prior start randomize treatment . This study design enable 60 participant evaluated effect first dose Prilosec OTC Zegerid Powder Oral Suspension change intragastric pH subsequent 24-hour period follow first dose .</detailed_description>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Omeprazole , sodium bicarbonate drug combination</mesh_term>
	<criteria>Normal subject 1865 year age . Nonchildbearing potential female use birth control . History hypersensitivity , allergy intolerance omeprazole proton pump inhibitor History significant gastrointestinal disease Any significant medical illness Gastrointestinal disorder surgery lead impaired drug absorption Currently use gastrointestinal medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>